Provided By GlobeNewswire
Last update: Nov 12, 2024
ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible and innovative therapeutic and diagnostic products, announces financial results for the quarter ended September 30, 2024 and provides a corporate update.
Read more at globenewswire.comNASDAQ:FEMY (4/29/2025, 8:00:00 PM)
1.17
+0.01 (+0.86%)
Find more stocks in the Stock Screener